Related Experiment Video

Updated: Jul 24, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.6K

[Research Progress of microRNA-7/124/155 in Parkinson's Disease]

Ting Chen1, Hao Chen1, Wei-Hong Yan1,2

  • 1Third Hospital of Shanxi Medical University,Shanxi Bethune Hospital,Shanxi Academy of Medical Sciences,Tongji Shanxi Hospital,Taiyuan 030032,China.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae
|July 5, 2023
PubMed

Insights

Parkinson's disease (PD) diagnosis is challenging due to early, non-specific symptoms. This review explores microRNAs (miRNAs) like miR-7, miR-124, and miR-155 as potential biomarkers for improved PD detection and understanding.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Parkinson's disease (PD) is a prevalent neurodegenerative disorder with significant disability.
  • Early PD symptoms are often non-specific, leading to diagnostic challenges and delayed treatment.
  • MicroRNAs (miRNAs) are key regulators of gene expression and emerging biomarkers.

Approach:

  • This review synthesizes recent research on specific miRNAs (miR-7, miR-124, miR-155) in Parkinson's disease.
  • It examines the role of these miRNAs in PD pathogenesis.
  • The potential of miRNAs as diagnostic and prognostic biomarkers for PD is explored.

Key Points:

  • miR-7, miR-124, and miR-155 are implicated in the development of Parkinson's disease.
  • Dysregulation of these miRNAs may contribute to PD pathology.
  • miRNAs are stable in body fluids, making them accessible biomarkers.

Conclusions:

  • Understanding the role of miR-7, miR-124, and miR-155 is crucial for elucidating PD pathogenesis.
  • These miRNAs show promise as diagnostic tools for early and accurate PD detection.
  • Targeting these miRNAs could offer novel therapeutic strategies for Parkinson's disease.
Keywords:
Parkinson’s diseasemicroRNA-124microRNA-155microRNA-7

More Related Videos

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.6K
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation13:36

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Published on: July 23, 2012

19.5K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
606
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
302
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K